Study on SARS-CoV-2 vaccination of HIV-infected patients and factors influencing SARS-CoV-2 infection in vaccinated patients in Northwest China

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069656

Enrollment

Unknown

Registered

2023-03-22

Start date

2023-03-30

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

human immunodeficiency virus infection

Interventions

Vaccination group:None

Non-vaccinated group:None

SARS-CoV-2 infection group:None

SARS-CoV-2 uninfected group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: HIV-infected patients aged 18 years and above in Gansu Province were enrolled.

Exclusion criteria

Exclusion criteria: Patients who did not sign the informed consent form.

Design outcomes

Primary

Measure	Time frame
CD4+T cell count;Coronavirus antibodies;IL-2;IL-4;IL-6;	—

Countries

China

Contacts

Public ContactLIting Zhang

The First Hospital of Lanzhou University

lcheneye@163.com13993173526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026